BackCTI BioPharma Overview

CTI BioPharma Other Liabilities

CTI BioPharma's other liabilities is $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00
100.00% YoYΔ $-1.83M vs prior year quarter

Peer average

Loading

CTI BioPharma Other Liabilities History

Loading

CTI BioPharma vs. peers: Other Liabilities Comparison

Loading

CTI BioPharma Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

CTI BioPharma (CTIC) FAQ

As of the most recent data (March 2023), CTIC shows a other liabilities of $0. That compares with $1.8M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CTIC's other liabilities is now $0 (was $1.8M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether CTI BioPharma is outperforming or lagging.

Tracking CTIC's other liabilities over time shows whether CTI BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $1.8M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has CTI BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $0) with ownership activity and broader fundamentals.

CTI BioPharma's other liabilities is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.